K.M. Kerr

Type de document

Articles (3) Recensions (2)

Co-auteur

S Peters

P. Zygoura

C. Wu

P. Wild

W. Weder

A. Warth

B. Vrugt

E. Verbeken

P.E. Van Schil

Z. Tsourti

E. Thunnissen

R.A. Stahel

R. Stahel

E.J. Speel

A. Soltermann

A. Sejda

K. Schulze

I. Sansano

U. Rulle

D. Nonaka

A. Navarro

K. Monkhorst

H. Moch

A. Marchetti

L.B. Madsen

R. Kammler

M. Haberecker

R.L. Haas

S. Gendreau

T. Geiger

S.P. Finn

D. Fennell

K.F. Deml

U. Dafni

A.T. Ciftlik

R. Cheney

R. Casanova

L. Bubendorf

P. Baas

Source

Serveur académique Lausannois (3)

Mot-clé

Human beings (3) Lungs (3) oncologie (2) survie (2) Diagnosis (2) Treatment (2) Survival (2) Patients (2) Oncology (2) Diagnosis (2) Cancer (2) Patients (2) tissu (corporel) (1) thérapie (1) surveillance (1) tabagisme (1) protocole (1) besoin (1) perte (1) anticorps (1) histoire (1) analyse (1) champ (1) investigation (1) adulte (1) biomarqueur (1) cancer (1) étalonnage (1) taux (1) Development (1)

Documents écrit par K.M. Kerr (3) | parle de K.M. Kerr (0)

Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry - Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort.

U. Rulle et al.

PD-1 blockade in advanced NSCLC: A focus on pembrolizumab.

S. Peters et al.

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

P. Baas et al.